Whole‐brain deuterium metabolic imaging via concentric ring trajectory readout enables assessment of regional variations in neuronal glucose metabolism
Human Brain Mapping · 2024
DOI: 10.1002/hbm.26686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Brain Mapping, 2024. Verfasst von Fabian Niess und 13 weiteren Autor:innen. Beteiligte Einrichtung: High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Glucose, Deuterium, Brain. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIBIB NIH HHS, NIH HHS.
Abstract (Originalsprache)
Deuterium metabolic imaging (DMI) is an emerging magnetic resonance technique, for non‐invasive mapping of human brain glucose metabolism following oral or intravenous administration of deuterium‐labeled glucose. Regional differences in glucose metabolism can be observed in various brain pathologies, such as Alzheimer's disease, cancer, epilepsy or schizophrenia, but the achievable spatial resolution of conventional phase‐encoded DMI methods is limited due to prolonged acquisition times rendering submilliliter isotropic spatial resolution for dynamic whole brain DMI not feasible. The purpose of this study was to implement non‐Cartesian spatial‐spectral sampling schemes for whole‐brain 2 H FID‐MR Spectroscopic Imaging to assess time‐resolved metabolic maps with sufficient spatial resolution to reliably detect metabolic differences between healthy gray and white matter regions. Results were compared with lower‐resolution DMI maps, conventionally acquired within the same session. Six healthy volunteers (4 m/2 f) were scanned for ~90 min after administration of 0.8 g/kg oral [6,6′]‐ 2 H glucose. Time‐resolved whole brain 2 H FID‐DMI maps of glucose (Glc) and glutamate + glutamine (Glx) were acquired with 0.75 and 2 mL isotropic spatial resolution using density‐weighted concentric ring trajectory (CRT) and conventional phase encoding (PE) readout, respectively, at 7 T. To minimize the effect of decreased signal‐to‐noise ratios associated with smaller voxels, low‐rank denoising of the spatiotemporal data was performed during reconstruction. Sixty‐three minutes after oral tracer uptake three‐dimensional (3D) CRT‐DMI maps featured 19% higher ( p = .006) deuterium‐labeled Glc concentrations in GM (1.98 ± 0.43 mM) compared with WM (1.66 ± 0.36 mM) dominated regions, across all volunteers. Similarly, 48% higher ( p = .01) 2 H‐Glx concentrations were observed in GM (2.21 ± 0.44 mM) compared with WM (1.49 ± 0.20 mM). Low‐resolution PE‐DMI maps acquired 70 min after tracer uptake featured smaller regional differences between GM‐ and WM‐dominated areas for 2 H‐Glc concentrations with 2.00 ± 0.35 mM and 1.71 ± 0.31 mM, respectively (+16%; p = .045), while no regional differences were observed for 2 H‐Glx concentrations. In this study, we successfully implemented 3D FID‐MRSI with fast CRT encoding for dynamic whole‐brain DMI at 7 T with 2.5‐fold increased spatial resolution compared with conventional whole‐brain phase encoded (PE) DMI to visualize regional metabolic differences. The faster metabolic activity represented by 48% higher Glx concentrations was observed in GM‐ compared with WM‐dominated regions, which could not be reproduced using whole‐brain DMI with the low spatial resolution protocol. Improved assessment of regional pathologic alterations using a fully non‐invasive imaging method is of high clinical relevance and could push DMI one step toward clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
- Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
- Christian Doppler Laboratory for MR Imaging Biomarkers (BIOMAK), Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
- Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria.
- Institute for Clinical Molecular MRI, Karl Landsteiner Society, St. Pölten, Austria.
- Department of Psychiatry and Psychotherapy, Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Fabian Niess, Rupert Lanzenberger
Förderung
- Wellcome Trust
- NIBIB NIH HHS
- NIH HHS
- Austrian Science Fund
- National Institutes of Health
- European Commission
- Christian Doppler Forschungsgesellschaft
Zitieren
APA
Niess, F., Strasser, B., Hingerl, L., Bader, V., Frese, S., Clarke, W. T., Duguid, A., Niess, E., Motyka, S., Krššák, M., Trattnig, S., Scherer, T., Lanzenberger, R., & Bogner, W. (2024). Whole‐brain deuterium metabolic imaging via concentric ring trajectory readout enables assessment of regional variations in neuronal glucose metabolism. Human Brain Mapping. https://doi.org/10.1002/hbm.26686
Vancouver
Niess F, Strasser B, Hingerl L, Bader V, Frese S, Clarke WT, et al. Whole‐brain deuterium metabolic imaging via concentric ring trajectory readout enables assessment of regional variations in neuronal glucose metabolism. Human Brain Mapping. 2024. doi:10.1002/hbm.26686
BibTeX
@article{Niess2024,
author = {Niess, Fabian and Strasser, Bernhard and Hingerl, Lukas and Bader, Viola and Frese, Sabina and Clarke, William T and Duguid, Anna and Niess, Eva and Motyka, Stanislav and Krššák, Martin and Trattnig, Siegfried and Scherer, Thomas and Lanzenberger, Rupert and Bogner, Wolfgang},
title = {Whole‐brain deuterium metabolic imaging via concentric ring trajectory readout enables assessment of regional variations in neuronal glucose metabolism},
journal = {Human Brain Mapping},
year = {2024},
doi = {10.1002/hbm.26686}
}
EUVIMED